We are actively
integrating discoveries in
diagnostic, therapeutic,
and information
technologies to create
the finest cancer
disease diagnostics.

CCC Diagnostics, Inc to Present Breast Cancer Study Results at Paris Conference

06/10/2010 – CCC Diagnostics, in conjunction with Dr. Katherine Tkaczuk of the University of Maryland Greenebaum Cancer Center, will present data describing expanded clinical studies of the DirectHit® Panel for Breast Cancer at the 2nd Worldwide Innovative Networking (WIN) in personalized cancer medicine conference on July 7, 2010 in Paris, France. Full Press Release

CCC Diagnostics, Inc launches new website for the DirectHit® Test Panel for Breast Cancer

04/29/2010 – CCC Diagnostics, Inc. today launched their new website, directhittest.com to support the DirectHit® Test Panel for Breast Cancer. DirectHit is a vastly improved diagnostic test for breast cancer treatment that accurately predicts the tumor’s response to four commonly prescribed classes of anti-cancer drugs. Full Press Release

CCC Diagnostics Launches Improved Test for Breast Cancer Treatment

01/14/2010 – CCC Diagnostics, Inc., headquartered in Baltimore, Maryland, today announced that it has launched ”DirectHit test panel,” a vastly improved diagnostic test for breast cancer treatment that accurately predicts the tumor’s response to four commonly prescribed classes of anti-cancer drugs.
Full Press Release

John Hughes named CEO of CCC Diagnostics

12/09/2009 – CCC Diagnostics has announced that its board of directors has named John Hughes to serve as the company’s chief executive officer and president. John brings an extensive business management and technical background that will be applied to development and marketing of DirectHit® Tests. Mr. Hughes is also president and founder of Rhythm & Hues Studios, a leading producer of computer generated character animation and visual effects for entertainment and advertising. Headquartered in Los Angeles with additional facilities in Mumbai, Hyderabad and Kuala Lumpur, Rhythm & Hues has approximately 1000 employees worldwide. John is committed to providing a collaborative and supportive work environment in pursuit of the highest levels of technical excellence. John will assume his new duties immediately. He will succeed Dr. Paul Ts’o, the founder of CCC Diagnostics, who passed away earlier this month.

CCC Diagnostics Announces Expanded Insurance Coverage for the Drug Response Indicator Test

12/08/2009 – Comprehensive Cancer Cell Diagnostics, Inc. (CCCD), announced today that the Centers for Medicare & Medicaid Services will provide coverage for their Drug Response Indicator Test (DRIT), trademarked as the Breast Cancer DirectHitTM Test Panel. In addition to Medicare, several other major health insurance companies have provided coverage for the test.
Full Press Release

Gastrointestinal Cancer DRIT Data Presented at 2009 ADAPT Congress

9/23/09 – CCC Diagnostics, in conjunction with Dr. Naimish Pandya of the University of Maryland Greenebaum Cancer Center and Dr. David Van Echo of HarborView Hospital in Baltimore, MD, presented a poster describing developmental clinical studies of the DirectHit™ (DRIT) Gastrointestinal Cancer Panel at the ADAPT Congress in Washington D.C. The retrospective studies encompass prediction of response to drugs used in the treatment of esophageal, rectal, colon, pancreatic, gastric and duodenal cancers.

CCC Diagnostics Launches CLIA Compliant Diagnostic Testing Laboratory

09/04/2009, Baltimore, MD - Comprehensive Cancer Cell Diagnostics (CCCD) has launched a CLIA compliant testing laboratory to market the Breast Cancer DirectHitTM Panel as a diagnostic service. The DirectHit Panel™ Service analyzes an individual patient’s tumor in order to indicate the sensitivity/resistance to FDAapproved, National Comprehensive Cancer Network (NCCN) recommended, chemotherapy drugs currently on the market.
Full Press Release

CCC Diagnostics Accepted as a Participating Provider by Wellpoint

07/15/2009 – WellPoint Unicare and/or HealthLink Networks have accepted CCCD as a participating provider. WellPoint family of companies is dedicated to developing health plans to improve and maintain members’ health. WellPoint Unicare and/or HealthLink Networks consist of:
FULL LIST OF WELLPOINT INSURERS